Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Heres what we do know from the few human reports available, and why they offer limited reassurance: Phase I trial (unpublished): In 2015, a formal Phase I trial on 42 healthy volunteers was initiated to assess BPC-157s safety and pharmacokinetics
Nausea, reduced appetite, and changes in food preferences typically stem from GLP-1 receptor activation in the appetite centers
References Bachem
Ghafourifar P, Schenk U, Klein SD, Richter C
GHK-Cu levels decline with age, and exogenous administration has been shown to stimulate collagen synthesis, accelerate wound healing, and modulate expression of genes involved in tissue remodeling
It stimulates fibroblast and keratinocyte proliferation, aiding re-epithelialization and ECM remodeling
US$ 24.95
US$ 29.78
US$ 22.34
US$ 24.85
US$ 28.70
US$ 26.10
